Viagra gets quick approval in Japan, opening big sales frontier for Pfizer

Article Abstract:

Pfizer Inc.'s Viagra impotence drug was given unusually rapid approval by Japan's Ministry of Health and Welfare. The approval means the opening up of what could be a very lucrative market for the Viagra drug. Viagra's Japanese unit is expecting to begin selling the drug in Japan by February or March 1999. The unit would not predict how many sales the drug would see in Japan. However, one analyst predicts that the drug will sell more than 10 billion yen in 1999.

Comment:

Viagra impotence drug given unusually rapid approval by Japan's Ministry of Health and Welfare

Japan, Product introduction, Pharmaceutical Preparation Manufacturing, Hormones & Related Preparations, Abstract, Pfizer Inc., PFE

---

EU opens antitrust probe with raid on drug makers

Article Abstract:

The European Union has launched an investigation into unfair competition within the pharmaceutical industry. Raids were conducted on drug firms in several EU-bloc nations to determine whether the firms were preventing competitors from marketing less-expensive generic forms of their branded drugs. The EU did not release the names of the firms searched.

Europe, Legal issues & crime, International economic relations, Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Antitrust Law, Company legal issue, Investigations, European Union, Antitrust issue, Trade policy

---

Similar abstracts:

• Abstracts: PetroChina domestic IPO gets approval. PetroChina clears IPO hurdle and shares rise. Roc Oil to drill in Angola: onshore exploration would be the first after years of unrest
• Abstracts: Commerce goes Canadian: purchase of quirky regional bank shows power of the "Loonie". Highbridge sets role in energy with venture
• Abstracts: U.K. regulator may require investors to disclose holdings. U.K.'s Synapse closes fund weighed down by mortgages
• Abstracts: Pfizer's strategy takes shape; Europe sales team may be cut deeply; reorganizing R&D. J&J profit rises on drug strength, Medicare switch
• Abstracts: Yukos Ex-Chief sentenced to 9 years. CAO Singapore's debacle has banks seeking payback. Rosneft names Finance Chief

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.